{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:13:44Z","timestamp":1760044424931},"reference-count":34,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1590\/s0100-879x2002000200016","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T16:41:58Z","timestamp":1113410518000},"page":"261-269","source":"Crossref","is-referenced-by-count":17,"title":["Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450"],"prefix":"10.1590","volume":"35","author":[{"given":"M.P.","family":"Marques","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.M.","family":"Takayanagui","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.L.","family":"Lanchote","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archneur.1992.00530270106026","article-title":"Therapy for neurocysticercosis: comparison between albendazole and praziquantel","volume":"49","author":"Takayanagui OM","year":"1992","journal-title":"Archives of Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.1995.00540250110021","article-title":"Medical treatment of cysticercosis - effective","volume":"529","author":"Del Brutto OH","year":"1995","journal-title":"Archives of Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2165\/00003088-199834060-00006","article-title":"Pharmacokinetic optimisation of the treatment of neurocysticercosis","volume":"34","author":"Sotelo J","year":"1998","journal-title":"Clinical Pharmacokinetics","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00141060","article-title":"Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines","volume":"5","author":"Rolin S","year":"1989","journal-title":"Cell Biology and Toxicology","ISSN":"http:\/\/id.crossref.org\/issn\/0742-2091","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2125.2000.00170.x","article-title":"Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes","volume":"49","author":"Rawden HC","year":"2000","journal-title":"British Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00498259109039463","article-title":"Comparative enantioselectivity in the sulfoxidation of albendazole in man, dogs and rats","volume":"21","author":"Delatour P","year":"1991","journal-title":"Xenobiotica","ISSN":"http:\/\/id.crossref.org\/issn\/0049-8254","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1520-636X(1999)11:3<218::AID-CHIR8>3.0.CO;2-G","article-title":"Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis","volume":"11","author":"Marques MPC","year":"1999","journal-title":"Chirality","ISSN":"http:\/\/id.crossref.org\/issn\/0899-0042","issn-type":"print"},{"key":"ref8","first-page":"160","article-title":"Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monoxygenases from rat liver microsomes","volume":"23","author":"Moroni P","year":"1995","journal-title":"Drug Metabolism and Disposition","ISSN":"http:\/\/id.crossref.org\/issn\/0090-9556","issn-type":"print"},{"key":"ref9","first-page":"758","article-title":"Albendazole sulfonation by rat liver cytochrome P-450c","volume":"246","author":"Amri HS","year":"1988","journal-title":"Journal of Pharmacology and Experimental Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2460\/ajvr.1992.53.09.1663","article-title":"Effect of repeated doses of albendazole on enantiomerism of its sulfoxide metabolite in goats","volume":"53","author":"Benoit E","year":"1992","journal-title":"American Journal of Veterinary Research","ISSN":"http:\/\/id.crossref.org\/issn\/0002-9645","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/clpt.1990.38","article-title":"Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance","volume":"47","author":"Steiger U","year":"1990","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002280050073","article-title":"Influence of renal failure on cytochrome P450 activity in hypertensive patients using a cocktail of antipyrine and nifedipine","volume":"50","author":"Lanchote VL","year":"1996","journal-title":"European Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0031-6970","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0009-9236(96)90001-6","article-title":"Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes, catalyzing 4-hydroxyantipyrine, 3 hydroxymethylantipyrine, and norantipyrine formation","volume":"59","author":"Engel G","year":"1996","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref14","first-page":"487","article-title":"Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine","volume":"24","author":"Sharer JE","year":"1996","journal-title":"Drug Metabolism and Disposition","ISSN":"http:\/\/id.crossref.org\/issn\/0090-9556","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-4347(98)00082-6","article-title":"Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma","volume":"709","author":"Lanchote VL","year":"1998","journal-title":"Journal of Chromatography. B, Biomedical Sciences and Applications","ISSN":"http:\/\/id.crossref.org\/issn\/1387-2273","issn-type":"print"},{"key":"ref16","first-page":"71","article-title":"A simple and sensitive high-performance liquid chromatographic method to measure antipyrine and its metabolites in human urine","volume":"32","author":"Lanchote VL","year":"1996","journal-title":"Revista de Farm\u00e1cia e Bioqu\u00edmica da Universidade de S\u00e3o Paulo"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00007691-199712000-00017","article-title":"Determination of antipyrine and metabolites in plasma of a patient with mild renal failure","volume":"19","author":"Lanchote VL","year":"1997","journal-title":"Therapeutic Drug Monitoring","ISSN":"http:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref18","series-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland M","year":"1989"},{"key":"ref19","series-title":"Pharmacokinetics","author":"Gibaldi M","year":"1982"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1988.tb03394.x","article-title":"Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a cocktail approach","volume":"26","author":"Schellens JHM","year":"1988","journal-title":"British Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450 and the clinical implications","volume":"35","author":"Lin JH","year":"1998","journal-title":"Clinical Pharmacokinetics","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: Ontogeny and drug disposition","volume":"37","author":"Wildt SN","year":"1999","journal-title":"Clinical Pharmacokinetics","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/BF00608219","article-title":"Pharmacokinetics of albendazole in man","volume":"30","author":"Marriner SE","year":"1986","journal-title":"European Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0031-6970","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002826-199302000-00009","article-title":"Pharmacokinetic comparison of two albendazole dosage regimens in patients with neurocysticercosis","volume":"16","author":"S\u00e1nchez M","year":"1993","journal-title":"Clinical Neuropharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0362-5664","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00007691-199702000-00009","article-title":"Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone","volume":"19","author":"Takayanagui OM","year":"1997","journal-title":"Therapeutic Drug Monitoring","ISSN":"http:\/\/id.crossref.org\/issn\/0163-4356","issn-type":"print"},{"key":"ref26","first-page":"188","article-title":"Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam","volume":"35","author":"Abernethy DR","year":"1984","journal-title":"Clinical Pharmacokinetics","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref27","first-page":"546P","article-title":"Influence of a single dose of cimetidine 800 mg and ranitidine 300 mg on oxidative drug transformation (antipyrine clearance)","volume":"20","author":"Friebel P","year":"1985","journal-title":"British Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/clpt.1984.79","article-title":"Cimetidine-induced reduction in gastrointestinal absorption of antipyrine and rate constants for formation of its metabolites","volume":"35","author":"Slusher LB","year":"1984","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.1985.tb05119.x","article-title":"Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine","volume":"20","author":"Shaw PN","year":"1985","journal-title":"British Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism: Role of CYP3A4 and CYPC8 in 10,11-epoxide formation","volume":"47","author":"Kerr BM","year":"1994","journal-title":"Biochemical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0006-2952","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2125.1988.tb05274.x","article-title":"Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy","volume":"26","author":"Patsalos PN","year":"1988","journal-title":"British Journal of Clinical Pharmacology","ISSN":"http:\/\/id.crossref.org\/issn\/0264-3774","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2165\/00003088-199631060-00005","article-title":"Pharmacokinetic interaction between antiepileptic drugs","volume":"31","author":"Riva R","year":"1996","journal-title":"Clinical Pharmacokinetics","ISSN":"http:\/\/id.crossref.org\/issn\/0312-5963","issn-type":"print"},{"key":"ref33","first-page":"105","article-title":"Dexamethasone metabolism by human liver in vitro: Metabolite identification and inhibition of 6-hydroxylation","volume":"277","author":"Gentile DM","year":"1996","journal-title":"Journal of Pharmacology and Experimental Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mcp.2000.110215","article-title":"In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone","volume":"68","author":"McCune JS","year":"2000","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v35n2\/4176.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T20:20:02Z","timestamp":1706127602000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2002000200016&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0100-879X2002000200016"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2002000200016","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}